Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 164

The DOI matches its Crossref record.

Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease

MASTERTON, G. S., PLEVRIS, J. N., HAYES, P. C. · 2010 · Alimentary Pharmacology & Therapeutics

Abstract

Aliment Pharmacol Ther 31, 679–692 Summary: Background Non‐alcoholic fatty liver disease affects 10–35% of the adult population worldwide; there is no consensus on its treatment. Omega‐3 fatty acids have proven benefits for hyperlipidaemia and cardiovascular disease, and have recently been suggested as a treatment for non‐alcoholic fatty liver disease. Aims To review the evidence base for omega‐3 fatty acids in non‐alcoholic fatty liver disease and critically appraise the literature relating to human trials. Methods A Medline and PubMed search was performed to identify relevant literature using search terms ‘omega‐3’, ‘N‐3 PUFA’, ‘eicosapentaenoic acid’, ‘docosahexaenoic acid’, ‘non‐alcoholic fatty liver disease’ and ‘NAFLD’. Results Omega‐3 fatty acids are important regulators of hepatic gene transcription. Animal studies demonstrate that they reduce hepatic steatosis, improve insulin sensitivity and reduce markers of inflammation. Clinical trials in human subjects generally confirm these findings, but have significant design inadequacies. Conclusions Omega‐3 fatty acids are a promising treatment for non‐alcoholic fatty liver disease which require to be tested in randomized placebo‐controlled trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2009.04230.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 134

  1. 10.1016/S1665-2681(19)31820-4 · DOI · Paper page
  2. 10.1097/00004836-200203000-00013 · DOI · Paper page
  3. 10.1002/hep.510240410 · DOI
  4. 10.1016/S0140-6736(05)67402-8 · DOI · Paper page
  5. Prashanth M, 2009, Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus, J Assoc Physicians India, 57, 205
  6. 10.1111/j.1440-1746.2006.04781.x · DOI · Paper page
  7. 10.2337/diabetes.54.11.3140 · DOI · Paper page
  8. 10.3748/wjg.v13.i10.1579 · DOI · Paper page
  9. 10.1111/j.1572-0241.2008.02034.x · DOI · Paper page
  10. 10.1016/S0016-5085(98)70599-2 · DOI · Paper page
  11. 10.1002/hep.21763 · DOI · Paper page
  12. 10.1016/j.mam.2007.09.014 · DOI
  13. 10.1111/j.1749-6632.1999.tb07793.x · DOI · Paper page
  14. 10.1097/MOG.0b013e3282fbccf2 · DOI · Paper page
  15. 10.1172/JCI200319246 · DOI · Paper page
  16. 10.1530/eje.1.01821 · DOI · Paper page
  17. 10.1038/nri1937 · DOI · Paper page
  18. 10.1097/MCG.0b013e31815e4079 · DOI
  19. 10.1016/j.jhep.2007.06.020 · DOI · Paper page
  20. 10.1016/j.mehy.2008.07.008 · DOI
  21. 10.1592/phco.27.5.715 · DOI
  22. Jacobson TA, 2006, Secondary prevention of coronary artery disease with omega‐3 fatty acids, Am J Cardiol, 98, 6170, 10.1016/j.amjcard.2005.12.028 · DOI
  23. 10.1093/ajcn/71.1.224s · DOI · Paper page
  24. 10.2174/1871520610909040457 · DOI
  25. 10.1017/S0954422408998620 · DOI
  26. 10.1007/s12017-008-8036-z · DOI · Paper page
  27. 10.1159/000074898 · DOI · Paper page
  28. 10.1097/00075197-200503000-00003 · DOI · Paper page
  29. 10.1016/j.jhep.2007.08.005 · DOI · Paper page
  30. 10.1097/01.mcg.0000225515.28536.3a · DOI
  31. 10.1097/MOL.0b013e3282f2e2a8 · DOI · Paper page
  32. 10.1016/j.freeradbiomed.2004.06.033 · DOI · Paper page
  33. 10.1042/CS20030326 · DOI · Paper page
  34. 10.1016/j.jhep.2007.09.009 · DOI · Paper page
  35. 10.1097/MOL.0b013e3282ffaf6a · DOI · Paper page
  36. 10.1161/01.RES.0000127122.22685.0A · DOI · Paper page
  37. 10.1097/00041433-199912000-00011 · DOI
  38. 10.1016/j.chemphyslip.2008.02.007 · DOI
  39. 10.1053/jhep.2003.50307 · DOI · Paper page
  40. 10.1002/hep.20170 · DOI · Paper page
  41. 10.1016/S1097-2765(00)80467-0 · DOI · Paper page
  42. 10.1074/jbc.M306238200 · DOI · Paper page
  43. 10.1016/j.ejphar.2006.02.028 · DOI · Paper page
  44. 10.1161/CIRCULATIONAHA.104.475673 · DOI · Paper page
  45. 10.1210/en.2007-0014 · DOI · Paper page
  46. 10.1172/JCI0215593 · DOI · Paper page
  47. 10.1073/pnas.96.22.12737 · DOI · Paper page
  48. Azzout‐Marniche D, 2000, Insulin effects on sterol regulatory‐element‐binding protein‐1c (SREBP‐1c) transcriptional activity in rat hepatocytes, Biochem J, 350, 389, 10.1042/bj3500389 · DOI · Paper page
  49. 10.1194/jlr.M500365-JLR200 · DOI · Paper page
  50. 10.1172/JCI119248 · DOI · Paper page
  51. 10.1074/jbc.274.50.35840 · DOI · Paper page
  52. 10.1074/jbc.M105711200 · DOI · Paper page
  53. 10.1074/jbc.M008973200 · DOI · Paper page
  54. 10.1074/jbc.274.33.23577 · DOI · Paper page
  55. 10.1074/jbc.273.40.25537 · DOI · Paper page
  56. 10.1074/jbc.274.36.25892 · DOI · Paper page
  57. 10.1152/ajpendo.1996.270.2.E353 · DOI
  58. 10.1210/en.2003-0479 · DOI
  59. 10.1146/annurev.nutr.25.051804.101917 · DOI · Paper page
  60. 10.1146/annurev.cellbio.16.1.459 · DOI · Paper page
  61. 10.1074/jbc.M307973200 · DOI
  62. 10.1042/bj20020340 · DOI
  63. 10.1172/JCI21025 · DOI · Paper page
  64. Davidson MH, 2006, Mechanisms for the hypotriglyceridemic effect of marine omega‐3 fatty acids.[see comment], Am J Cardiol, 98, 2733, 10.1016/j.amjcard.2005.12.024 · DOI · Paper page
  65. 10.1172/JCI25256 · DOI · Paper page
  66. 10.1074/jbc.M601277200 · DOI
  67. 10.2337/db06-0200 · DOI · Paper page
  68. 10.1074/jbc.272.43.26827 · DOI · Paper page
  69. 10.1042/bj3410371 · DOI
  70. 10.1016/j.plipres.2004.05.004 · DOI · Paper page
  71. 10.1007/s11745-997-0022-3 · DOI
  72. 10.1056/NEJM199301283280404 · DOI · Paper page
  73. 10.1177/0148607100024003159 · DOI
  74. 10.1007/s11745-005-1443-8 · DOI
  75. 10.1111/j.1440-1746.2008.05543.x · DOI · Paper page
  76. 10.1016/j.jhep.2008.10.031 · DOI
  77. 10.1161/ATVBAHA.106.136853 · DOI · Paper page
  78. 10.1007/s11745-007-3039-3 · DOI
  79. 10.1203/01.PDR.0000153672.43030.75 · DOI · Paper page
  80. 10.1097/01.TP.0000150023.86487.44 · DOI
  81. 10.1016/j.plefa.2009.02.004 · DOI
  82. 10.1096/fj.08-125674 · DOI · Paper page
  83. 10.1016/j.hep.2003.09.028 · DOI · Paper page
  84. 10.2353/ajpath.2006.050953 · DOI · Paper page
  85. 10.1002/mnfr.200700315 · DOI
  86. 10.1111/j.1440-1746.2007.05157.x · DOI · Paper page
  87. 10.1002/hep.20093 · DOI
  88. 10.1590/S0100-879X2006000200004 · DOI
  89. 10.1074/jbc.M004045200 · DOI · Paper page
  90. 10.1093/jn/132.1.88 · DOI
  91. 10.1016/S0899-9007(00)00392-0 · DOI
  92. 10.1006/cimm.1995.1106 · DOI · Paper page
  93. 10.1007/s00125-005-0053-y · DOI · Paper page
  94. 10.1111/j.1365-2036.2006.02885.x · DOI · Paper page
  95. 10.1016/j.dld.2007.10.003 · DOI · Paper page
  96. 10.1097/MCG.0b013e31815591aa · DOI · Paper page
  97. 10.1016/S0168-8278(02)00331-8 · DOI · Paper page
  98. 10.2310/JIM.0b013e318177024d · DOI
  99. 10.1002/hep.20466 · DOI · Paper page
  100. 10.1111/j.1365-2036.2007.03246.x · DOI · Paper page
  101. 10.1053/jhep.2003.50320 · DOI · Paper page
  102. 10.1111/j.1572-0241.2005.41334.x · DOI · Paper page
  103. 10.1136/gut.2003.027581 · DOI · Paper page
  104. 10.1002/hep.23276 · DOI · Paper page
  105. 10.1111/j.1572-0241.2003.07375.x · DOI
  106. 10.1002/hep.22575 · DOI · Paper page
  107. Sabuncu T, 2003, The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non‐alcoholic steatohepatitis, Rom J Gastroenterol, 12, 189
  108. 10.1111/j.1478-3231.2007.01555.x · DOI
  109. 10.1002/hep.20251 · DOI · Paper page
  110. 10.1007/s11695-007-9086-2 · DOI · Paper page
  111. 10.1016/j.cgh.2008.08.012 · DOI · Paper page
  112. 10.1111/j.1440-1746.2007.04833.x · DOI · Paper page
  113. 10.1016/S0140-6736(01)06042-1 · DOI · Paper page
  114. 10.1111/j.1365-2036.2005.02420.x · DOI · Paper page
  115. 10.1016/j.clinthera.2008.06.012 · DOI
  116. 10.1111/j.1572-0241.2005.41583.x · DOI · Paper page
  117. 10.1111/j.1365-2036.2008.03869.x · DOI · Paper page
  118. 10.1111/j.1572-0241.2001.03553.x · DOI · Paper page
  119. 10.1002/hep.1840380427 · DOI · Paper page
  120. 10.1002/hep.20012 · DOI · Paper page
  121. 10.1053/j.gastro.2008.03.078 · DOI · Paper page
  122. 10.1056/NEJMoa060326 · DOI · Paper page
  123. 10.1046/j.1365-2036.2001.01083.x · DOI · Paper page
  124. 10.1111/j.1572-0241.2003.08699.x · doi:10.1111/j.1572-0241.2003.08699.x · Paper page
  125. 10.1053/jhep.2003.50316 · DOI · Paper page
  126. 10.1016/S0168-8278(02)00441-5 · DOI
  127. 10.1111/j.1572-0241.2004.40220.x · DOI · Paper page
  128. 10.1111/j.1572-0241.2004.40064.x · DOI · Paper page
  129. 10.1002/hep.20092 · DOI · Paper page
  130. 10.1002/hep.20420 · DOI · Paper page
  131. 10.3748/wjg.15.942 · DOI · Paper page
  132. 10.1111/j.1572-0241.2001.04129.x · doi:10.1111/j.1572-0241.2001.04129.x · Paper page
  133. 10.1046/j.1440-1746.2003.03156.x · DOI
  134. 10.1007/s10620-006-8030-y · DOI

Cited by

See all 164

Metadata

Authors
MASTERTON, G. S., PLEVRIS, J. N., & HAYES, P. C.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2010-03
Volume
31
Issue
7
Pages
679-692
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2616752079
Cited by
164
References
0
FWCI
9.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease. https://app.cochat.ai/papers/10.1111/j.1365-2036.2009.04230.x
The paper
MASTERTON, G. S., PLEVRIS, J. N., & HAYES, P. C. (2010). Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2009.04230.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.